Drugs target to SMN1

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophySurvival motor neuron protein positive modulator3.0CompletedClinicalTrials
ONASEMNOGENE ABEPARVOVECGenedistal spinal muscular atrophy type 3Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGeneX-linked distal arthrogryposis multiplex congenitaSurvival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGeneProximal spinal muscular atrophy type 2Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGeneSpinal muscular atrophy with respiratory distress type 1Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophySurvival motor neuron protein positive modulator3.0Not yet recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophy, type 1Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGeneDistal hereditary motor neuropathy type 1Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGeneProximal spinal muscular atrophy type 3Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGenedistal hereditary motor neuropathy type 2Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophySurvival motor neuron protein positive modulator1.0CompletedClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophy, type IISurvival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophy with respiratory distress type 2Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials